Table 1.
Study Parameters | ncsPCa | csPCa |
---|---|---|
No. of patients | 26 | 50 |
Mean ± SD | ||
Age (years) | 65 ± 8.8 | 66 ± 6.8 |
PSA (ng/mL) | 5.30 ± 2.97 | 7.80 ± 7.48 |
Range | ||
Age (years) | [42÷78] | [48÷79] |
PSA (ng/mL) | [0.80÷12.20] | [0.38÷37.00] |
Lesions’ location | ||
PZ | 25 | 64 |
TZ | - | 1 |
CZ | 8 | 10 |
PZ-TZ 1 | 2 | 1 |
PZ-CZ 1 | 1 | 3 |
AFS | - | 1 |
No. of lesions per PiRADS score | ||
PI-RADS 3 | 16 | 15 |
PI-RADS 4 | 16 | 34 |
PI-RADS 5 | 4 | 33 |
No. of lesions per GS | ||
GS 3 + 3 (ISUP 1) | 26 | |
GS 3 + 4 (ISUP 2) | - | 22 |
GS 4 + 3 (ISUP 3) | - | 14 |
GS 4 + 4 (ISUP 4) | - | 8 |
GS 4 + 5 (ISUP 5) | - | 4 |
GS 5 + 5 (ISUP 5) | - | 2 |
1 Partial overlapping between zones.